Depression and patterns of self-reported adherence to antiretroviral therapy in Rwanda

International Journal of STD and AIDS

Volumn 26, Issue 4, 2015, Pages 257-261

  Wroe, Emily B ^a,b   Hedt Gauthier, Bethany L ^b,c,d   Franke, Molly F ^b,c   Nsanzimana, Sabin ^e   Turinimana, Jean Bosco ^b   Drobac, Peter ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PARTNERS IN HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF RWANDA   (Rwanda)

^e RWANDA BIOMEDICAL CENTER   (Rwanda)

Author keywords

adherence; Africa; AIDS; antiretroviral therapy; depression; HIV; screening; treatment; viral disease

Indexed keywords

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; DEPRESSION; FEMALE; HEALTH AUXILIARY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; TREATMENT REFUSAL; CROSS-SECTIONAL STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MIDDLE AGED; OUTCOME ASSESSMENT; PREVALENCE; PSYCHOLOGY; RURAL POPULATION; RWANDA; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PREVALENCE; RURAL POPULATION; RWANDA; SELF REPORT; YOUNG ADULT;

EID: 84923268000     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462414535206     Document Type: Article

References (31)

1. World Health Organization, Country Health Profile, Rwanda. http://www.who.int/countries/rwa/en/ (accessed 23 September 2012).
2. Logie DE,Rowson M,Ndagije F.Innovations in Rwanda’s health system: looking to the future.Lancet. 2008;372:256-261
3. Farmer PE,Nutt CT,Wagner CM, et al.Reduced premature mortality in Rwanda: lessons from success.BMJ. 2013;346:f65-f65
4. National Institute of Statistics of Rwanda. The third integrated household living conditions survey (EICV3). 2012. www.statistics.gov.rw/publications/third-integrated-household-living-conditions-survey-eicv-3-main-indicators-report (accessed 17 March 2013).
5. Nsanzimana S,Ruton H,Lowrance DW, et al.Cell phone-based and internet-based monitoring and evaluation of the national antiretroviral treatment program during rapid scale-up in Rwanda: TRACnet, 2004–2010.J Acquir Immune Defic Syndr. 2012;59:e17-e23
6. Oyugi JH,Byakika-Tusiime J,Ragland K, et al.Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.AIDS. 2007;21:965-971
7. Mills EJ,Nachega JB,Buchan I, et al.Adherence to antiretroviral therapy in sub-saharan Africa and North America.JAMA. 2006;296:679-690
8. Nachega JB,Mills EJ,Schechter M.Antiretroviral therapy adherence and retention in care in middle-income and low–income countries: current status of knowledge and research priorities.Curr Opin HIV AIDS. 2010;5:70-77
9. Hardon AP,Akurut D,Comoro C, et al.Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa.AIDS Care. 2007;19:658-665
10. Mills EJ,Nachega JB,Bangsberg DR, et al.Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.PLoS Med. 2006;3:e438-e438
11. Castro A.Adherence to antiretroviral therapy: merging the clinical and social course of AIDS.PLoS Med. 2005;2:e338-e338
12. Reda AA,Biadgilign S.Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa.AIDS Res Treat. 2012;2012:574656-574656
13. Franke MF,Kaigamba F,Socci AR, et al.Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.Clin Infect Dis. 2013;56:1319-1326
14. Ciesla JA,Roberts JE.Meta-analysis of the relationship between HIV infection and risk for depressive disorders.Am J Psychiatry. 2001;158:725-730
15. Wagner GJ,Goggin K,Remien RH, et al.A closer look at depression and its relationship to HIV antiretroviral adherence.Ann Behav Med. 2011;42:352-360
16. Ickovics JR,Hamburger ME,Vlahov D, et al.Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study.JAMA. 2001;285:1466-1474
17. Carrico AW,Riley ED,Johnson MO, et al.Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization.J Acquir Immune Defic Syndr. 2011;56:146-150
18. DiMatteo MR,Lepper HS,Croghan TW.Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.Arch Intern Med. 2000;160:2101-2107
19. Gonzalez JS,Batchelder AW,Psaros C, et al.Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis.J Acquir Immune Defic Syndr. 2011;58:181-187
20. Sethi AK,Celentano DD,Gange SJ, et al.Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.Clin Infect Dis. 2003;37:1112-1118
21. Chesney MA,Morin M,Sherr L.Adherence to HIV combination therapy.Soc Sci Med. 2000;50:1599-1605
22. Mannheimer SB,Mukherjee R,Hirschhorn LR, et al.The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy.AIDS Care. 2006;18:853-861
23. Derogatis LR,Lipman RS,Covi L.SCL-90: an outpatient psychiatric rating scale—preliminary report.Psychopharmacol Bull. 1973;9:13-18
24. Lee PW,Schulberg HC,Raue PJ, et al.Concordance between the PHQ-9 and the HSCL-20 in depressed primary care patients.J Affect Disord. 2007;99:139-145
25. Epino HM, Rich ML, Kaigamba F, et al. Reliability and construct validity of three health-related self-report scales in HIV-positive adults in rural Rwanda. AIDS Care Epub ahead of print 19 Mar 2012.
26. Murray CJ,Lopez AD.Global mortality, disability, and the contribution of risk factors: global burden of disease study.Lancet. 1997;349:1436-1442
27. Tegger MK,Crane HM,Tapia KA, et al.The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.AIDS Patient Care STDS. 2008;22:233-243
28. Bhatia R,Hartman C,Kallen MA, et al.Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the steps study.AIDS Behav. 2011;15:1161-1170
29. Holzemer WL,Corless IB,Nokes KM, et al.Predictors of self-reported adherence in persons living with HIV disease.AIDS Patient Care STDS. 1999;13:185-197
30. Fairfield KM,Libman H,Davis RB, et al.Delays in protease inhibitor use in clinical practice.J Gen Intern Med. 1999;14:395-401
31. Thomson DR, Rich ML, Kaigamba F, et al. Community-based accompaniment and psychosocial health outcomes in HIV-infected adults in Rwanda: a prospective study. AIDS Behav Epub ahead of print 27 Feb 2013.